Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001144204-17-062471

Executive Chairman disposed of 356,683 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WEIL A LORNE Executive Chairman 2017-12-05 Other disposition −187,166 307,545 D
WEIL A LORNE Executive Chairman 2017-12-05 Other disposition −169,517 1,000,000 I
Loading xslF345X03/tv480821_4.xml…